Literature DB >> 10830617

Expression of a soluble functional form of the integrin alpha4beta1 in mammalian cells.

P E Stephens, S Ortlepp, V C Perkins, M K Robinson, H Kirby.   

Abstract

The integrin alpha4beta1(VLA4) has been expressed as a soluble, active, heterodimeric immunoglobulin fusion protein. cDNAs encoding the extracellular domains of the human alpha4 and beta1 subunits were fused to the genomic DNA encoding the human gamma1 immunoglobulin Fc domain and functional integrin fusion protein was expressed as a secreted, soluble molecule from a range of mammalian cell lines. Specific mutations were introduced into the Fc region of the molecules to promote alpha4beta1 heterodimer formation. The soluble alpha4beta1-Fc fusion protein exhibited divalent cation dependent binding to VCAM-1, which was blocked by the appropriate function blocking antibodies. The apparent Kd for VCAM-1 binding were similar for both the soluble and native forms of alpha4beta1. In addition, the integrin-Fc fusion was shown to stain cells expressing VCAM-1 on their surface by FACs analysis. This approach for expressing soluble alpha4beta1 should be generally applicable to a range of integrins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10830617     DOI: 10.3109/15419060009109020

Source DB:  PubMed          Journal:  Cell Adhes Commun        ISSN: 1023-7046


  4 in total

Review 1.  Two distinct lymphocyte homing systems involved in the pathogenesis of chronic inflammatory gastrointestinal diseases.

Authors:  Motohiro Kobayashi; Hitomi Hoshino; Kenichi Suzawa; Yasuhiro Sakai; Jun Nakayama; Minoru Fukuda
Journal:  Semin Immunopathol       Date:  2012-05-10       Impact factor: 9.623

2.  An integrin alpha4beta7•IgG heterodimeric chimera binds to MAdCAM-1 on high endothelial venules in gut-associated lymphoid tissue.

Authors:  Hitomi Hoshino; Motohiro Kobayashi; Junya Mitoma; Yoshiko Sato; Minoru Fukuda; Jun Nakayama
Journal:  J Histochem Cytochem       Date:  2011-03-23       Impact factor: 2.479

3.  Molecular basis for the dynamic strength of the integrin alpha4beta1/VCAM-1 interaction.

Authors:  Xiaohui Zhang; Susan E Craig; Hishani Kirby; Martin J Humphries; Vincent T Moy
Journal:  Biophys J       Date:  2004-09-03       Impact factor: 4.033

4.  A tumor-associated beta 1 integrin mutation that abrogates epithelial differentiation control.

Authors:  Richard D Evans; Vivienne C Perkins; Alistair Henry; Paul E Stephens; Martyn K Robinson; Fiona M Watt
Journal:  J Cell Biol       Date:  2003-02-10       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.